Clin Exp Otorhinolaryngol.  2019 May;12(2):107-144. 10.21053/ceo.2018.01816.

Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery

• Korean Society of Thyroid-Head and Neck Surgery Guideline Task Force
• Joo YH
• Cho JK
• Koo BS
• Kwon M
• Kwon SK
• Kwon SY
• Kim MS
• Kim JK
• Kim H
• Nam I
• Roh JL
• Park YM
• Park IS
• Park JJ
• Shin SC
• Ahn SH
• Won S
• Ryu CH
• Yoon TM
• Lee G
• Lee DY
• Lee MC
• Lee JK
• Lee JC
• Lim JY
• Chang JW
• Jang JY
• Chung MK
• Jung YS
• Cho JG
• Choi YS
• Choi JS
• Lee GH
• Chung PS

• KMID: 2447421
• DOI: http://doi.org/10.21053/ceo.2018.01816

Abstract

Korean Society of Thyroid-Head and Neck Surgery appointed a Task Force to provide guidance on the implementation of a surgical treatment of oral cancer. MEDLINE databases were searched for articles on subjects related to "surgical management of oral cancer" published in English. Results were restricted to systematic reviews, randomized control trials/controlled clinical trials, and observational studies. The quality of evidence was rated with use RoBANS (Risk of Bias Assessment Tool for Nonrandomized Studies) and AMSTAR (A Measurement Tool to Assess the Methodological Quality of Systematic Reviews). Evidence-based recommendations for practice were ranked according to the American College of Physicians grading system. Additional directives are provided as expert opinions and Delphi questionnaire when insufficient evidence existed. The Committee developed 68 evidence-based recommendations in 34 categories intended to assist clinicians and patients and counselors, and health policy-makers. Proper surgical treatment selection for oral cancer, which is directed by patient- and subsite-specific factors, remains the greatest predictor of successful treatment outcomes. These guidelines are intended for use in conjunction with the individual patient's treatment goals.

Keyword

Mouth Neoplasms; Squamous Cell Carcinoma; Surgery; Guideline; Republic of Korea

MeSH Terms

Advisory Committees
Bias (Epidemiology)
Carcinoma, Squamous Cell
Counseling
Expert Testimony
Humans
Mouth Neoplasms*
Neck*
Republic of Korea

Reference

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; Mar. 65(2):87–108.

2. Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma: an update. CA Cancer J Clin. 2015; Sep-Oct. 65(5):401–21.

3. Tahir A, Nagi AH, Ullah E, Janjua OS. The role of mast cells and angiogenesis in well-differentiated oral squamous cell carcinoma. J Cancer Res Ther. 2013; Jul-Sep. 9(3):387–91.

4. Rogers SN, Brown JS, Woolgar JA, Lowe D, Magennis P, Shaw RJ, et al. Survival following primary surgery for oral cancer. Oral Oncol. 2009; Mar. 45(3):201–11.

5. Korean Society of Thyroid-Head, Neck Surgery Guideline Task Force, Ahn SH, Hong HJ, Kwon SY, Kwon KH, Roh JL, et al. Guidelines for the surgical management of laryngeal cancer: Korean Society of Thyroid-Head and Neck Surgery. Clin Exp Otorhinolaryngol. 2017; Mar. 10(1):1–43.

6. Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS, Hahn S, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013; Apr. 66(4):408–14.

7. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007; Feb. 7:10.

8. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007; Nov. 36(10):575–80.

9. Carreras-Torras C, Gay-Escoda C. Techniques for early diagnosis of oral squamous cell carcinoma: systematic review. Med Oral Patol Oral Cir Bucal. 2015; May. 20(3):e305–15.

10. Omar E. Current concepts and future of noninvasive procedures for diagnosing oral squamous cell carcinoma: a systematic review. Head Face Med. 2015; Mar. 11:6.

11. Macey R, Walsh T, Brocklehurst P, Kerr AR, Liu JL, Lingen MW, et al. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev. 2015; May. (5):CD010276.

12. Forman MS, Chuang SK, August M. The accuracy of clinical diagnosis of oral lesions and patient-specific risk factors that affect diagnosis. J Oral Maxillofac Surg. 2015; Oct. 73(10):1932–7.

13. Wang YY, Tail YH, Wang WC, Chen CY, Kao YH, Chen YK, et al. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders. BMC Oral Health. 2014; Aug. 14:99.

14. Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review. J Am Dent Assoc. 2014; Jan. 145(1):45–56.

15. Warnakulasuriya S, Kovacevic T, Madden P, Coupland VH, Sperandio M, Odell E, et al. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med. 2011; Oct. 40(9):677–83.

16. Brocklehurst P, Kujan O, O’Malley LA, Ogden G, Shepherd S, Glenny AM. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev. 2013; Nov. (11):CD004150.

17. Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet. 2005; Jun. 365(9475):1927–33.

18. Ramadas K, Sankaranarayanan R, Jacob BJ, Thomas G, Somanathan T, Mahe C, et al. Interim results from a cluster randomized controlled oral cancer screening trial in Kerala, India. Oral Oncol. 2003; Sep. 39(6):580–8.

19. Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Thomas G, Anju G, et al. Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India. Oral Oncol. 2013; Apr. 49(4):314–21.

20. Sankaranarayanan R, Mathew B, Jacob BJ, Thomas G, Somanathan T, Pisani P, et al. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer. 2000; Feb. 88(3):664–73.

21. Lazarus CL, Husaini H, Anand SM, Jacobson AS, Mojica JK, Buchbinder D, et al. Tongue strength as a predictor of functional outcomes and quality of life after tongue cancer surgery. Ann Otol Rhinol Laryngol. 2013; Jun. 122(6):386–97.

22. Laaksonen JP, Rieger J, Happonen RP, Harris J, Seikaly H. Speech after radial forearm free flap reconstruction of the tongue: a longitudinal acoustic study of vowel and diphthong sounds. Clin Linguist Phon. 2010; Jan. 24(1):41–54.

23. Hartl DM, Dauchy S, Escande C, Bretagne E, Janot F, Kolb F. Quality of life after free-flap tongue reconstruction. J Laryngol Otol. 2009; May. 123(5):550–4.

24. Speksnijder CM, van der Bilt A, Abbink JH, Merkx MA, Koole R. Mastication in patients treated for malignancies in tongue and/or floor of mouth: a 1-year prospective study. Head Neck. 2011; Jul. 33(7):1013–20.

25. Villaret AB, Cappiello J, Piazza C, Pedruzzi B, Nicolai P. Quality of life in patients treated for cancer of the oral cavity requiring reconstruction: a prospective study. Acta Otorhinolaryngol Ital. 2008; Jun. 28(3):120–5.

26. Roumanas ED, Garrett N, Blackwell KE, Freymiller E, Abemayor E, Wong WK, et al. Masticatory and swallowing threshold performances with conventional and implant-supported prostheses after mandibular fibula free-flap reconstruction. J Prosthet Dent. 2006; Oct. 96(4):289–97.

27. Curtis DA, Plesh O, Miller AJ, Curtis TA, Sharma A, Schweitzer R, et al. A comparison of masticatory function in patients with or without reconstruction of the mandible. Head Neck. 1997; Jul. 19(4):287–96.

28. Teoh KH, Patel S, Hwang F, Huryn JM, Verbel D, Zlotolow IM. Prosthetic intervention in the era of microvascular reconstruction of the mandible: a retrospective analysis of functional outcome. Int J Prosthodont. 2005; Jan-Feb. 18(1):42–54.

29. Matsui Y, Neukam FW, Schmelzeisen R, Ohno K. Masticatory function of postoperative tumor patients rehabilitated with osseointegrated implants. J Oral Maxillofac Surg. 1996; Apr. 54(4):441–7.

30. Jung YS, Lim J, Jung KW, Ryu J, Won YJ. Metachronous second primary malignancies after head and neck cancer in a Korean cohort (1993-2010). PLoS One. 2015; Jul. 10(7):e0134160.

31. Tiwana MS, Hay J, Wu J, Wong F, Cheung W, Olson RA. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years. Laryngoscope. 2014; Oct. 124(10):2287–91.

32. Gan SJ, Dahlstrom KR, Peck BW, Caywood W, Li G, Wei Q, et al. Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer. 2013; Jul. 119(14):2593–601.

33. Chen MC, Chen PT, Chan CH, Yang CT, Chen CC, Huang CE, et al. Second primary esophageal or lung cancer in patients with head and neck carcinoma in Taiwan: incidence and risk in relation to primary index tumor site. J Cancer Res Clin Oncol. 2011; Jan. 137(1):115–23.

34. Atienza JA, Dasanu CA. Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature. Curr Med Res Opin. 2012; Dec. 28(12):1899–909.

35. Chuang SC, Scelo G, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer. 2008; Nov. 123(10):2390–6.

36. Lin K, Patel SG, Chu PY, Matsuo JM, Singh B, Wong RJ, et al. Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck. 2005; Dec. 27(12):1042–8.

37. van der Waal I, de Bree R. Second primary tumours in oral cancer. Oral Oncol. 2010; Jun. 46(6):426–8.

38. Hsu SH, Wong YK, Wang CP, Wang CC, Jiang RS, Chen FJ, et al. Survival analysis of patients with oral squamous cell carcinoma with simultaneous second primary tumors. Head Neck. 2013; Dec. 35(12):1801–7.

39. Liao CT, Fan KH, Kang CJ, Lin CY, Chang JT, Tsang NM, et al. Clinical outcomes of patients with resected oral cavity cancer and simultaneous second primary malignancies. PLoS One. 2015; Sep. 10(9):e0136918.

40. Hsu YB, Chang SY, Lan MC, Huang JL, Tai SK, Chu PY. Second primary malignancies in squamous cell carcinomas of the tongue and larynx: an analysis of incidence, pattern, and outcome. J Chin Med Assoc. 2008; Feb. 71(2):86–91.

41. Griffioen GH, Louie AV, de Bree R, Smit EF, Paul MA, Slotman BJ, et al. Second primary lung cancers following a diagnosis of primary head and neck cancer. Lung Cancer. 2015; Apr. 88(1):94–9.

42. Lim H, Kim DH, Jung HY, Gong EJ, Na HK, Ahn JY, et al. Clinical significance of early detection of esophageal cancer in patients with head and neck cancer. Gut Liver. 2015; Mar. 9(2):159–65.

43. Xu GZ, Guan DJ, He ZY. (18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer: a meta-analysis. Oral Oncol. 2011; Jul. 47(7):560–5.

44. Stoeckli SJ, Zimmermann R, Schmid S. Role of routine panendoscopy in cancer of the upper aerodigestive tract. Otolaryngol Head Neck Surg. 2001; Feb. 124(2):208–12.

45. Hung SH, Tsai MC, Liu TC, Lin HC, Chung SD. Routine endoscopy for esophageal cancer is suggestive for patients with oral, oropharyngeal and hypopharyngeal cancer. PLoS One. 2013; Aug. 8(8):e72097.

46. Su YY, Chen WC, Chuang HC, Guo CS, Lin YT, Luo SD, et al. Effect of routine esophageal screening in patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2013; Apr. 139(4):350–4.

47. Yabuki K, Kubota A, Horiuchi C, Taguchi T, Nishimura G, Inamori M. Limitations of PET and PET/CT in detecting upper gastrointestinal synchronous cancer in patients with head and neck carcinoma. Eur Arch Otorhinolaryngol. 2013; Feb. 270(2):727–33.

48. Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck. 2010; Mar. 32(3):319–25.

49. Page C, Lucas-Gourdet E, Biet-Hornstein A, Strunski V. Initial staging of head and neck squamous cell carcinoma: what is the place of bronchoscopy and upper GI endoscopy. Eur Arch Otorhinolaryngol. 2015; Mar. 272(3):705–9.

50. McLeod NM, Jess A, Anand R, Tilley E, Higgins B, Brennan PA. Role of chest CT in staging of oropharyngeal cancer: a systematic review. Head Neck. 2009; Apr. 31(4):548–55.

51. Ritoe SC, Krabbe PF, Jansen MM, Festen J, Joosten FB, Kaanders JH, et al. Screening for second primary lung cancer after treatment of laryngeal cancer. Laryngoscope. 2002; Nov. 112(11):2002–8.

52. Kerawala C, Roques T, Jeannon JP, Bisase B. Oral cavity and lip cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016; May. 130(S2):S83–9.

53. Dammann F, Horger M, Mueller-Berg M, Schlemmer H, Claussen CD, Hoffman J, et al. Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET. AJR Am J Roentgenol. 2005; Apr. 184(4):1326–31.

54. Blatt S, Ziebart T, Kruger M, Pabst AM. Diagnosing oral squamous cell carcinoma: how much imaging do we really need? A review of the current literature. J Craniomaxillofac Surg. 2016; May. 44(5):538–49.

55. Arya S, Rane P, Deshmukh A. Oral cavity squamous cell carcinoma: role of pretreatment imaging and its influence on management. Clin Radiol. 2014; Sep. 69(9):916–30.

56. Arya S, Rane P, Sable N, Juvekar S, Bal M, Chaukar D. Retromolar trigone squamous cell cancers: a reappraisal of 16 section MDCT for assessing mandibular invasion. Clin Radiol. 2013; Dec. 68(12):e680–8.

57. Handschel J, Naujoks C, Depprich RA, Kubler NR, Kropil P, Kuhlemann J, et al. CT-scan is a valuable tool to detect mandibular involvement in oral cancer patients. Oral Oncol. 2012; Apr. 48(4):361–6.

58. Uribe S, Rojas LA, Rosas CF. Accuracy of imaging methods for detection of bone tissue invasion in patients with oral squamous cell carcinoma. Dentomaxillofac Radiol. 2013; 42(6):20120346.

59. Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst. 2008; May. 100(10):712–20.

60. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, et al. Analysis of risk factors of predictive local tumor control in oral cavity cancer. Ann Surg Oncol. 2008; Mar. 15(3):915–22.

61. Yoon DY, Hwang HS, Chang SK, Rho YS, Ahn HY, Kim JH, et al. CT, MR, US,18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol. 2009; Mar. 19(3):634–42.

62. Park S, Jee SH, Shin HR, Park EH, Shin A, Jung KW, et al. Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea. BMC Cancer. 2014; Jun. 14:406.

63. Park JO, Jung SL, Joo YH, Jung CK, Cho KJ, Kim MS. Diagnostic accuracy of magnetic resonance imaging (MRI) in the assessment of tumor invasion depth in oral/oropharyngeal cancer. Oral Oncol. 2011; May. 47(5):381–6.

64. Seitz O, Chambron-Pinho N, Middendorp M, Sader R, Mack M, Vogl TJ, et al. 18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen. Neuroradiology. 2009; Oct. 51(10):677–86.

65. Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med. 2005; Jul. 46(7):1136–43.

66. Lam P, Au-Yeung KM, Cheng PW, Wei WI, Yuen AP, Trendell-Smith N, et al. Correlating MRI and histologic tumor thickness in the assessment of oral tongue cancer. AJR Am J Roentgenol. 2004; Mar. 182(3):803–8.

67. Preda L, Chiesa F, Calabrese L, Latronico A, Bruschini R, Leon ME, et al. Relationship between histologic thickness of tongue carcinoma and thickness estimated from preoperative MRI. Eur Radiol. 2006; Oct. 16(10):2242–8.

68. Gu DH, Yoon DY, Park CH, Chang SK, Lim KJ, Seo YL, et al. CT, MR, (18)F-FDG PET/CT, and their combined use for the assessment of mandibular invasion by squamous cell carcinomas of the oral cavity. Acta Radiol. 2010; Dec. 51(10):1111–9.

69. Vidiri A, Guerrisi A, Pellini R, Manciocco V, Covello R, Mattioni O, et al. Multi-detector row computed tomography (MDCT) and magnetic resonance imaging (MRI) in the evaluation of the mandibular invasion by squamous cell carcinomas (SCC) of the oral cavity: correlation with pathological data. J Exp Clin Cancer Res. 2010; Jun. 29:73.

70. Sarrion Perez MG, Bagan JV, Jimenez Y, Margaix M, Marzal C. Utility of imaging techniques in the diagnosis of oral cancer. J Craniomaxillofac Surg. 2015; Nov. 43(9):1880–94.

71. Wolff KD, Follmann M, Nast A. The diagnosis and treatment of oral cavity cancer. Dtsch Arztebl Int. 2012; Nov. 109(48):829–35.

72. Rege S, Maass A, Chaiken L, Hoh CK, Choi Y, Lufkin R, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer. 1994; Jun. 73(12):3047–58.

73. Schoder H, Yeung HW. Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med. 2004; Jul. 34(3):180–97.

74. Hannah A, Scott AM, Tochon-Danguy H, Chan JG, Akhurst T, Berlangieri S, et al. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg. 2002; Aug. 236(2):208–17.

75. Higashi K, Clavo AC, Wahl RL. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med. 1993; Mar. 34(3):414–9.

76. Haberkorn U, Strauss LG, Reisser C, Haag D, Dimitrakopoulou A, Ziegler S, et al. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med. 1991; Aug. 32(8):1548–55.

77. Stuckensen T, Kovacs AF, Adams S, Baum RP. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg. 2000; Dec. 28(6):319–24.

78. Bakhshayesh Karam M, Doroudinia A, Safavi Nainee A, Kaghazchi F, Yousefi Koma A, Mehrian P, et al. Role of FDG PET/CT scan in head and neck cancer patients. Arch Iran Med. 2017; Jul. 20(7):452–8.

79. Abd El-Hafez YG, Chen CC, Ng SH, Lin CY, Wang HM, Chan SC, et al. Comparison of PET/CT and MRI for the detection of bone marrow invasion in patients with squamous cell carcinoma of the oral cavity. Oral Oncol. 2011; Apr. 47(4):288–95.

80. Sureshkannan P, John R. Role of ultrasound in detection of metastatic neck nodes in patients with oral cancer. Indian J Dent Res. 2011; May-Jun. 22(3):419–23.

81. Geetha NT, Hallur N, Goudar G, Sikkerimath BC, Gudi SS. Cervical lymph node metastasis in oral squamous carcinoma preoperative assessment and histopathology after neck dissection. J Maxillofac Oral Surg. 2010; Mar. 9(1):42–7.

82. Haberal I, Celik H, Gocmen H, Akmansu H, Yoruk M, Ozeri C. Which is important in the evaluation of metastatic lymph nodes in head and neck cancer: palpation, ultrasonography, or computed tomography. Otolaryngol Head Neck Surg. 2004; Feb. 130(2):197–201.

83. Yamamoto C, Yuasa K, Okamura K, Shiraishi T, Miwa K. Vascularity as assessed by Doppler intraoral ultrasound around the invasion front of tongue cancer is a predictor of pathological grade of malignancy and cervical lymph node metastasis. Dentomaxillofac Radiol. 2016; 45(3):20150372.

84. Lodder WL, Teertstra HJ, Tan IB, Pameijer FA, Smeele LE, van Velthuysen ML, et al. Tumour thickness in oral cancer using an intra-oral ultrasound probe. Eur Radiol. 2011; Jan. 21(1):98–106.

85. Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst. 2007; May. 99(10):777–89.

86. Room R, Babor T, Rehm J. Alcohol and public health. Lancet. 2005; Feb. 365(9458):519–30.

87. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000; May. 92(9):709–20.

88. Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ, Madeleine MM, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998; Nov. 90(21):1626–36.

89. Lingen MW, Xiao W, Schmitt A, Jiang B, Pickard R, Kreinbrink P, et al. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol. 2013; Jan. 49(1):1–8.

90. Javed F, Warnakulasuriya S. Is there a relationship between periodontal disease and oral cancer? A systematic review of currently available evidence. Crit Rev Oncol Hematol. 2016; Jan. 97:197–205.

91. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008; Jul. 454(7203):436–44.

92. Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med. 2005; Jul. 3:27.

93. Hwang IM, Sun LM, Lin CL, Lee CF, Kao CH. Periodontal disease with treatment reduces subsequent cancer risks. QJM. 2014; Oct. 107(10):805–12.

94. Gupta B, Johnson NW. Emerging and established global life-style risk factors for cancer of the upper aero-digestive tract. Asian Pac J Cancer Prev. 2014; 15(15):5983–91.

95. Song M, Li QL, Li FJ, Chen SW, Zhuang SM, Wang LP, et al. Mandibular lingual release approach: an appropriate approach for total or subtotal glossectomy. Head Neck Oncol. 2013; Feb. 5(2):11.

96. Devine JC, Rogers SN, McNally D, Brown JS, Vaughan ED. A comparison of aesthetic, functional and patient subjective outcomes following lip-split mandibulotomy and mandibular lingual releasing access procedures. Int J Oral Maxillofac Surg. 2001; Jun. 30(3):199–204.

97. Na HY, Choi EJ, Choi EC, Kim HJ, Cha IH, Nam W. Modified mandibulotomy technique to reduce postoperative complications: 5-year results. Yonsei Med J. 2013; Sep. 54(5):1248–52.

98. Satpathy S, Dam A, Hossain MA, Chatterjee J. Double mandibular osteotomy with segmental mandibular swing approach to parapharyngeal space. Natl J Maxillofac Surg. 2014; Jul-Dec. 5(2):213–6.

99. Shah JP, Kumaraswamy SV, Kulkarni V. Comparative evaluation of fixation methods after mandibulotomy for oropharyngeal tumors. Am J Surg. 1993; Oct. 166(4):431–4.

100. Dziegielewski PT, Mlynarek AM, Dimitry J, Harris JR, Seikaly H. The mandibulotomy: friend or foe? Safety outcomes and literature review. Laryngoscope. 2009; Dec. 119(12):2369–75.

101. Dziegielewski PT, O’Connell DA, Rieger J, Harris JR, Seikaly H. The lip-splitting mandibulotomy: aesthetic and functional outcomes. Oral Oncol. 2010; Aug. 46(8):612–7.

102. Marchetta FC. Function and appearance following surgery for intraoral cancer. Clin Plast Surg. 1976; Jul. 3(3):471–9.

103. Al-Saleh MA, Armijo-Olivo S, Thie N, Seikaly H, Boulanger P, Wolfaardt J, et al. Morphologic and functional changes in the temporomandibular joint and stomatognathic system after transmandibular surgery in oral and oropharyngeal cancers: systematic review. J Otolaryngol Head Neck Surg. 2012; Oct. 41(5):345–60.

104. Pang P, Li RW, Shi JP, Xu ZF, Duan WY, Liu FY, et al. A comparison of mandible preservation method and mandibulotomy approach in oral and oropharyngeal cancer: a meta-analysis. Oral Oncol. 2016; Dec. 63:52–60.

105. Li H, Li J, Yang B, Su M, Xing R, Han Z. Mandibular lingual release versus mandibular lip-split approach for expanded resection of middle-late tongue cancer: a case-control study. J Craniomaxillofac Surg. 2015; Sep. 43(7):1054–8.

106. Masuda M, Fukushima J, Kadota H, Kamizono K, Ejima M, Taura M. Mandible preserving pull-through oropharyngectomy for advanced oropharyngeal cancer: a pilot study. Auris Nasus Larynx. 2011; Jun. 38(3):392–7.

107. Al-Rajhi N, Khafaga Y, El-Husseiny J, Saleem M, Mourad W, Al-Otieschan A, et al. Early stage carcinoma of oral tongue: prognostic factors for local control and survival. Oral Oncol. 2000; Nov. 36(6):508–14.

108. El-Husseiny G, Kandil A, Jamshed A, Khafaga Y, Saleem M, Allam A, et al. Squamous cell carcinoma of the oral tongue: an analysis of prognostic factors. Br J Oral Maxillofac Surg. 2000; Jun. 38(3):193–9.

109. Ling W, Mijiti A, Moming A. Survival pattern and prognostic factors of patients with squamous cell carcinoma of the tongue: a retrospective analysis of 210 cases. J Oral Maxillofac Surg. 2013; Apr. 71(4):775–85.

110. Sharma P, Shah SV, Taneja C, Patel AM, Patel MD. A prospective study of prognostic factors for recurrence in early oral tongue cancer. J Clin Diagn Res. 2013; Nov. 7(11):2559–62.

111. Vered M, Dayan D, Dobriyan A, Yahalom R, Shalmon B, Barshack I, et al. Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age. J Cancer Res Clin Oncol. 2010; Jul. 136(7):1039–48.

112. Yuen PW, Lam KY, Chan AC, Wei WI, Lam LK. Clinicopathological analysis of local spread of carcinoma of the tongue. Am J Surg. 1998; Mar. 175(3):242–4.

113. Mistry RC, Qureshi SS, Kumaran C. Post-resection mucosal margin shrinkage in oral cancer: quantification and significance. J Surg Oncol. 2005; Aug. 91(2):131–3.

114. Ganly I, Patel S, Shah J. Early stage squamous cell cancer of the oral tongue: clinicopathologic features affecting outcome. Cancer. 2012; Jan. 118(1):101–11.

115. Baek CH, Son YI, Jeong HS, Chung MK, Park KN, Ko YH, et al. Intraoral sonography-assisted resection of T1-2 tongue cancer for adequate deep resection. Otolaryngol Head Neck Surg. 2008; Dec. 139(6):805–10.

116. Campana JP, Meyers AD. The surgical management of oral cancer. Otolaryngol Clin North Am. 2006; Apr. 39(2):331–48.

117. Wolfensberger M, Zbaeren P, Dulguerov P, Muller W, Arnoux A, Schmid S. Surgical treatment of early oral carcinoma: results of a prospective controlled multicenter study. Head Neck. 2001; Jul. 23(7):525–30.

118. Larsen SR, Johansen J, Sorensen JA, Krogdahl A. The prognostic significance of histological features in oral squamous cell carcinoma. J Oral Pathol Med. 2009; Sep. 38(8):657–62.

119. Woolgar JA, Triantafyllou A. A histopathological appraisal of surgical margins in oral and oropharyngeal cancer resection specimens. Oral Oncol. 2005; Nov. 41(10):1034–43.

120. Alkureishi LW, Ross GL, Shoaib T, Soutar DS, Robertson AG, Sorensen JA, et al. Does tumor depth affect nodal upstaging in squamous cell carcinoma of the head and neck. Laryngoscope. 2008; Apr. 118(4):629–34.

121. Mark Taylor S, Drover C, Maceachern R, Bullock M, Hart R, Psooy B, et al. Is preoperative ultrasonography accurate in measuring tumor thickness and predicting the incidence of cervical metastasis in oral cancer. Oral Oncol. 2010; Jan. 46(1):38–41.

122. O’Brien CJ, Lauer CS, Fredricks S, Clifford AR, McNeil EB, Bagia JS, et al. Tumor thickness influences prognosis of T1 and T2 oral cavity cancer: but what thickness. Head Neck. 2003; Nov. 25(11):937–45.

123. Wallwork BD, Anderson SR, Coman WB. Squamous cell carcinoma of the floor of the mouth: tumour thickness and the rate of cervical metastasis. ANZ J Surg. 2007; Sep. 77(9):761–4.

124. Dirven R, Ebrahimi A, Moeckelmann N, Palme CE, Gupta R, Clark J. Tumor thickness versus depth of invasion: analysis of the 8th edition American Joint Committee on Cancer Staging for oral cancer. Oral Oncol. 2017; Nov. 74:30–3.

125. Anderson CR, Sisson K, Moncrieff M. A meta-analysis of margin size and local recurrence in oral squamous cell carcinoma. Oral Oncol. 2015; May. 51(5):464–9.

126. Eskander A, Givi B, Gullane PJ, Irish J, Brown D, Gilbert RW, et al. Outcome predictors in squamous cell carcinoma of the maxillary alveolus and hard palate. Laryngoscope. 2013; Oct. 123(10):2453–8.

127. Seoane J, Varela-Centelles PI, Walsh TF, Lopez-Cedrun JL, Vazquez I. Gingival squamous cell carcinoma: diagnostic delay or rapid invasion. J Periodontol. 2006; Jul. 77(7):1229–33.

128. Bark R, Mercke C, Munck-Wikland E, Wisniewski NA, Hammarstedt-Nordenvall L. Cancer of the gingiva. Eur Arch Otorhinolaryngol. 2016; Jun. 273(6):1335–45.

129. Yang Z, Deng R, Sun G, Huang X, Tang E. Cervical metastases from squamous cell carcinoma of hard palate and maxillary alveolus: a retrospective study of 10 years. Head Neck. 2014; Jul. 36(7):969–75.

130. Alonso JE, Han AY, Kuan EC, Strohl M, Clair JM, St John MA, et al. The survival impact of surgical therapy in squamous cell carcinoma of the hard palate. Laryngoscope. 2018; Sep. 128(9):2050–5.

131. Aydil U, Kizil Y, Bakkal FK, Koybasioglu A, Uslu S. Neoplasms of the hard palate. J Oral Maxillofac Surg. 2014; Mar. 72(3):619–26.

132. Stern SJ, GS H, Clayman G, Byers R, Ang KK, el-Naggar AK, et al. Squamous cell carcinoma of the maxillary sinus. Arch Otolaryngol Head Neck Surg. 1993; Sep. 119(9):964–9.

133. Petrovic I, Montero PH, Migliacci JC, Palmer FL, Ganly I, Patel SG, et al. Influence of bone invasion on outcomes after marginal mandibulectomy in squamous cell carcinoma of the oral cavity. J Craniomaxillofac Surg. 2017; Feb. 45(2):252–7.

134. McGregor AD, MacDonald DG. Routes of entry of squamous cell carcinoma to the mandible. Head Neck Surg. 1988; May-Jun. 10(5):294–301.

135. Namin AW, Bruggers SD, Panuganti BA, Christopher KM, Walker RJ, Varvares MA. Efficacy of bone marrow cytologic evaluations in detecting occult cancellous invasion. Laryngoscope. 2015; May. 125(5):E173–9.

136. Wysluch A, Stricker I, Holzle F, Wolff KD, Maurer P. Intraoperative evaluation of bony margins with frozen-section analysis and trephine drill extraction technique: a preliminary study. Head Neck. 2010; Nov. 32(11):1473–8.

137. Weitz J, Pautke C, Wolff KD, Kolk A. Can the inferior alveolar nerve be used as a marker in frozen section for free margin control after segmental mandibulectomy in tumour ablation. Int J Oral Maxillofac Surg. 2016; Nov. 45(11):1366–71.

138. Nieberler M, Haussler P, Kesting MR, Kolk A, Deppe H, Weirich G, et al. Clinical impact of intraoperative cytological assessment of bone resection margins in patients with head and neck carcinoma. Ann Surg Oncol. 2016; Oct. 23(11):3579–86.

139. Barttelbort SW, Ariyan S. Mandible preservation with oral cavity carcinoma: rim mandibulectomy versus sagittal mandibulectomy. Am J Surg. 1993; Oct. 166(4):411–5.

140. Lubek JE, Magliocca KR. Evaluation of the bone margin in oral squamous cell carcinoma. Oral Maxillofac Surg Clin North Am. 2017; Aug. 29(3):281–92.

141. Rao LP, Shukla M, Sharma V, Pandey M. Mandibular conservation in oral cancer. Surg Oncol. 2012; Jun. 21(2):109–18.

142. Brown J. Mechanisms of cancer invasion of the mandible. Curr Opin Otolaryngol Head Neck Surg. 2003; Apr. 11(2):96–102.

143. Brown JS, Browne RM. Factors influencing the patterns of invasion of the mandible by oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 1995; Dec. 24(6):417–26.

144. Wong RJ, Keel SB, Glynn RJ, Varvares MA. Histological pattern of mandibular invasion by oral squamous cell carcinoma. Laryngoscope. 2000; Jan. 110(1):65–72.

145. Shaw RJ, Brown JS, Woolgar JA, Lowe D, Rogers SN, Vaughan ED. The influence of the pattern of mandibular invasion on recurrence and survival in oral squamous cell carcinoma. Head Neck. 2004; Oct. 26(10):861–9.

146. Shaha AR. Marginal mandibulectomy for carcinoma of the floor of the mouth. J Surg Oncol. 1992; Feb. 49(2):116–9.

147. Muscatello L, Lenzi R, Pellini R, Giudice M, Spriano G. Marginal mandibulectomy in oral cancer surgery: a 13-year experience. Eur Arch Otorhinolaryngol. 2010; May. 267(5):759–64.

148. Pandey M, Rao LP, Das SR. Predictors of mandibular involvement in cancers of the oromandibular region. J Oral Maxillofac Surg. 2009; May. 67(5):1069–73.

149. Gou L, Yang W, Qiao X, Ye L, Yan K, Li L, et al. Marginal or segmental mandibulectomy: treatment modality selection for oral cancer: a systematic review and meta-analysis. Int J Oral Maxillofac Surg. 2018; Jan. 47(1):1–10.

150. Shah JP, Gil Z. Current concepts in management of oral cancer: surgery. Oral Oncol. 2009; Apr-May. 45(4-5):394–401.

151. Wax MK, Bascom DA, Myers LL. Marginal mandibulectomy vs segmental mandibulectomy: indications and controversies. Arch Otolaryngol Head Neck Surg. 2002; May. 128(5):600–3.

152. O’Brien CJ, Adams JR, McNeil EB, Taylor P, Laniewski P, Clifford A, et al. Influence of bone invasion and extent of mandibular resection on local control of cancers of the oral cavity and oropharynx. Int J Oral Maxillofac Surg. 2003; Oct. 32(5):492–7.

153. Wolff D, Hassfeld S, Hofele C. Influence of marginal and segmental mandibular resection on the survival rate in patients with squamous cell carcinoma of the inferior parts of the oral cavity. J Craniomaxillofac Surg. 2004; Oct. 32(5):318–23.

154. Priya SR, D’Cruz AK, Pai PS. Cut margins and disease control in oral cancers. J Cancer Res Ther. 2012; Jan-Mar. 8(1):74–9.

155. Boonstra H, Oosterhuis JW, Oosterhuis AM, Fleuren GJ. Cervical tissue shrinkage by formaldehyde fixation, paraffin wax embedding, section cutting and mounting. Virchows Arch A Pathol Anat Histopathol. 1983; 402(2):195–201.

156. Chen CH, Hsu MY, Jiang RS, Wu SH, Chen FJ, Liu SA. Shrinkage of head and neck cancer specimens after formalin fixation. J Chin Med Assoc. 2012; Mar. 75(3):109–13.

157. Park HS, Lee S, Haam S, Lee GD. Effect of formalin fixation and tumour size in small-sized non-small-cell lung cancer: a prospective, single-centre study. Histopathology. 2017; Sep. 71(3):437–45.

158. Silverman MK, Golomb FM, Kopf AW, Grin-Jorgensen CM, Vossaert KA, Doyle JP, et al. Verification of a formula for determination of preexcision surgical margins from fixed-tissue melanoma specimens. J Am Acad Dermatol. 1992; Aug. 27(2 Pt 1):214–9.

159. Siu KF, Cheung HC, Wong J. Shrinkage of the esophagus after resection for carcinoma. Ann Surg. 1986; Feb. 203(2):173–6.

160. Johnson RE, Sigman JD, Funk GF, Robinson RA, Hoffman HT. Quantification of surgical margin shrinkage in the oral cavity. Head Neck. 1997; Jul. 19(4):281–6.

161. Egemen O, Bingol D, Orman C, Sayilgan AT, Ozkaya O, Akan M. Quantification of the surgical margin shrinkage in lip cancer: determining the relation between the surgical and histopathologic margins. J Craniofac Surg. 2014; Nov. 25(6):2152–5.

162. Chen YL, Kuo SW, Fang KH, Hao SP. Prognostic impact of marginal mandibulectomy in the presence of superficial bone invasion and the nononcologic outcome. Head Neck. 2011; May. 33(5):708–13.

163. Clark JR, Franklin JH, Naranjo N, Odell MJ, Gullane PJ. Sublingual gland resection in squamous cell carcinoma of the floor of mouth: is it necessary. Laryngoscope. 2006; Mar. 116(3):382–6.

164. Nason RW, Sako K, Beecroft WA, Razack MS, Bakamjian VY, Shedd DP. Surgical management of squamous cell carcinoma of the floor of the mouth. Am J Surg. 1989; Oct. 158(4):292–6.

165. Kaya I, Ozturk K, Turhal G. Sublingual lymph node metastasis in early-stage floor of the mouth carcinoma. Turk Arch Otorhinolaryngol. 2017; Dec. 55(4):177–9.

166. Umeda M, Minamikawa T, Shigeta T, Oguni A, Kataoka T, Takahashi H, et al. Metastasis to the lingual lymph node in patients with squamous cell carcinoma of the floor of the mouth: a report of two cases. Kobe J Med Sci. 2010; Feb. 55(3):E67–72.

167. Rodgers GK, Myers EN. Surgical management of the mass in the buccal space. Laryngoscope. 1988; Jul. 98(7):749–53.

168. Lubek JE, Dyalram D, Perera EH, Liu X, Ord RA. A retrospective analysis of squamous carcinoma of the buccal mucosa: an aggressive subsite within the oral cavity. J Oral Maxillofac Surg. 2013; Jun. 71(6):1126–31.

169. Diaz EM Jr, Holsinger FC, Zuniga ER, Roberts DB, Sorensen DM. Squamous cell carcinoma of the buccal mucosa: one institution’s experience with 119 previously untreated patients. Head Neck. 2003; Apr. 25(4):267–73.

170. Ota Y, Aoki T, Karakida K, Otsuru M, Kurabayashi H, Sasaki M, et al. Determination of deep surgical margin based on anatomical architecture for local control of squamous cell carcinoma of the buccal mucosa. Oral Oncol. 2009; Jul. 45(7):605–9.

171. Lore JM, Medina JE. An atlas of head and neck surgery. 4th ed. Philadelphia (PA): Elsevier;2006.

172. Farah CS, Dalley AJ, Nguyen P, Batstone M, Kordbacheh F, Perry-Keene J, et al. Improved surgical margin definition by narrow band imaging for resection of oral squamous cell carcinoma: a prospective gene expression profiling study. Head Neck. 2016; Jun. 38(6):832–9.

173. Jan JC, Hsu WH, Liu SA, Wong YK, Poon CK, Jiang RS, et al. Prognostic factors in patients with buccal squamous cell carcinoma: 10-year experience. J Oral Maxillofac Surg. 2011; Feb. 69(2):396–404.

174. Luryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL. Treatment factors associated with survival in early-stage oral cavity cancer: analysis of 6,830 cases from the National Cancer Data Base. JAMA Otolaryngol Head Neck Surg. 2015; Jul. 141(7):593–8.

175. Mishra A, Datta S, Malik A, Garg A, Nair D, Nair S, et al. Role of microscopic spread beyond gross disease as an adverse prognostic factor in oral squamous cell carcinoma. Eur J Surg Oncol. 2017; Aug. 43(8):1503–8.

176. Lin HY, Huang TT, Lee MS, Hung SK, Lin RI, Tseng CE, et al. Unexpected close surgical margin in resected buccal cancer: very close margin and DAPK promoter hypermethylation predict poor clinical outcomes. Oral Oncol. 2013; Apr. 49(4):336–44.

177. Buchakjian MR, Tasche KK, Robinson RA, Pagedar NA, Sperry SM. Association of main specimen and tumor bed margin status with local recurrence and survival in oral cancer surgery. JAMA Otolaryngol Head Neck Surg. 2016; Dec. 142(12):1191–8.

178. Gokavarapu S, Rao LM, Mahajan M, Parvataneni N, Raju KV, Chander R. Revision of margins under frozen section in oral cancer: a retrospective study of involved margins in pT1 and pT2 oral cancers. Br J Oral Maxillofac Surg. 2015; Nov. 53(9):875–9.

179. Mair M, Nair D, Nair S, Dutta S, Garg A, Malik A, et al. Intraoperative gross examination vs frozen section for achievement of adequate margin in oral cancer surgery. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017; May. 123(5):544–9.

180. Tirelli G, Piovesana M, Gatto A, Tofanelli M, Biasotto M, Boscolo Nata F. Narrow band imaging in the intra-operative definition of resection margins in oral cavity and oropharyngeal cancer. Oral Oncol. 2015; Oct. 51(10):908–13.

181. Tirelli G, Piovesana M, Gatto A, Torelli L, Boscolo Nata F. Is NBI-guided resection a breakthrough for achieving adequate resection margins in oral and oropharyngeal squamous cell carcinoma. Ann Otol Rhinol Laryngol. 2016; Jul. 125(7):596–601.

182. Chen TC, Wang CP, Ko JY, Yang TL, Lou PJ. The impact of pathologic close margin on the survival of patients with early stage oral squamous cell carcinoma. Oral Oncol. 2012; Jul. 48(7):623–8.

183. Liao CT, Huang SF, Chen IH, Chang JT, Wang HM, Ng SH, et al. When does skin excision allow the achievement of an adequate local control rate in patients with squamous cell carcinoma involving the buccal mucosa. Ann Surg Oncol. 2008; Aug. 15(8):2187–94.

184. Trivedi NP, Kekatpure VD, Shetkar G, Gangoli A, Kuriakose MA. Pathology of advanced buccal mucosa cancer involving masticator space (T4b). Indian J Cancer. 2015; Oct-Dec. 52(4):611–5.

185. Antoniades K, Lazaridis N, Vahtsevanos K, Hadjipetrou L, Antoniades V, Karakasis D. Treatment of squamous cell carcinoma of the anterior faucial pillar-retromolar trigone. Oral Oncol. 2003; Oct. 39(7):680–6.

186. Byers RM, Anderson B, Schwarz EA, Fields RS, Meoz R. Treatment of squamous carcinoma of the retromolar trigone. Am J Clin Oncol. 1984; Dec. 7(6):647–52.

187. Hao SP, Tsang NM, Chang KP, Chen CK, Huang SS. Treatment of squamous cell carcinoma of the retromolar trigone. Laryngoscope. 2006; Jun. 116(6):916–20.

188. Lane AP, Buckmire RA, Mukherji SK, Pillsbury HC 3rd, Meredith SD. Use of computed tomography in the assessment of mandibular invasion in carcinoma of the retromolar trigone. Otolaryngol Head Neck Surg. 2000; May. 122(5):673–7.

189. Lam KH, Lam LK, Ho CM, Wei WI. Mandibular invasion in carcinoma of the lower alveolus. Am J Otolaryngol. 1999; Sep-Oct. 20(5):267–72.

190. Ayad T, Guertin L, Soulieres D, Belair M, Temam S, Nguyen-Tan PF. Controversies in the management of retromolar trigone carcinoma. Head Neck. 2009; Mar. 31(3):398–405.

191. Dijkstra PU, Huisman PM, Roodenburg JL. Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg. 2006; Apr. 35(4):337–42.

192. Garnett MJ, Nohl FS, Barclay SC. Management of patients with reduced oral aperture and mandibular hypomobility (trismus) and implications for operative dentistry. Br Dent J. 2008; Feb. 204(3):125–31.

193. Scott B, Butterworth C, Lowe D, Rogers SN. Factors associated with restricted mouth opening and its relationship to health-related quality of life in patients attending a maxillofacial oncology clinic. Oral Oncol. 2008; May. 44(5):430–8.

194. Verdonck-de Leeuw IM, van Bleek WJ, Leemans CR, de Bree R. Employment and return to work in head and neck cancer survivors. Oral Oncol. 2010; Jan. 46(1):56–60.

195. Cohen EG, Deschler DG, Walsh K, Hayden RE. Early use of a mechanical stretching device to improve mandibular mobility after composite resection: a pilot study. Arch Phys Med Rehabil. 2005; Jul. 86(7):1416–9.

196. Lee R, Slevin N, Musgrove B, Swindell R, Molassiotis A. Prediction of post-treatment trismus in head and neck cancer patients. Br J Oral Maxillofac Surg. 2012; Jun. 50(4):328–32.

197. Tsai CC, Wu SL, Lin SL, Ko SY, Chiang WF, Yang JW. Reducing trismus after surgery and radiotherapy in oral cancer patients: results of alternative operation versus traditional operation. J Oral Maxillofac Surg. 2016; May. 74(5):1072–83.

198. Dijkstra PU, Kalk WW, Roodenburg JL. Trismus in head and neck oncology: a systematic review. Oral Oncol. 2004; Oct. 40(9):879–89.

199. Dias FL, Lima RA, Kligerman J, Farias TP, Soares JR, Manfro G, et al. Relevance of skip metastases for squamous cell carcinoma of the oral tongue and the floor of the mouth. Otolaryngol Head Neck Surg. 2006; Mar. 134(3):460–5.

200. Jerjes W, Upile T, Petrie A, Riskalla A, Hamdoon Z, Vourvachis M, et al. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients. Head Neck Oncol. 2010; Apr. 2:9.

201. Fasunla AJ, Greene BH, Timmesfeld N, Wiegand S, Werner JA, Sesterhenn AM. A meta-analysis of the randomized controlled trials on elective neck dissection versus therapeutic neck dissection in oral cavity cancers with clinically node-negative neck. Oral Oncol. 2011; May. 47(5):320–4.

202. Keski-Santti H, Atula T, Tornwall J, Koivunen P, Makitie A. Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue. Oral Oncol. 2006; Jan. 42(1):96–101.

203. Okura M, Aikawa T, Sawai NY, Iida S, Kogo M. Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. Oral Oncol. 2009; Oct. 45(10):908–11.

204. Po Wing Yuen A, Lam KY, Lam LK, Ho CM, Wong A, Chow TL, et al. Prognostic factors of clinically stage I and II oral tongue carcinoma: a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck. 2002; Jun. 24(6):513–20.

205. Fakih AR, Rao RS, Borges AM, Patel AR. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg. 1989; Oct. 158(4):309–13.

206. Rodrigo JP, Shah JP, Silver CE, Medina JE, Takes RP, Robbins KT, et al. Management of the clinically negative neck in early-stage head and neck cancers after transoral resection. Head Neck. 2011; Aug. 33(8):1210–9.

207. Asakage T, Yokose T, Mukai K, Tsugane S, Tsubono Y, Asai M, et al. Tumor thickness predicts cervical metastasis in patients with stage I/II carcinoma of the tongue. Cancer. 1998; Apr. 82(8):1443–8.

208. Kurokawa H, Yamashita Y, Takeda S, Zhang M, Fukuyama H, Takahashi T. Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue. Head Neck. 2002; Aug. 24(8):731–6.

209. Kligerman J, Lima RA, Soares JR, Prado L, Dias FL, Freitas EQ, et al. Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg. 1994; Nov. 168(5):391–4.

210. Brazilian Head, Neck Cancer Study Group. Results of a prospective trial on elective modified radical classical versus supraomohyoid neck dissection in the management of oral squamous carcinoma. Am J Surg. 1998; Nov. 176(5):422–7.

211. Chone CT, Silva AR, Crespo AN, Schlupp WR. Regional tumor recurrence after supraomohyoid neck dissection. Arch Otolaryngol Head Neck Surg. 2003; Jan. 129(1):54–8.

212. Hao SP, Tsang NM. The role of supraomohyoid neck dissection in patients of oral cavity carcinoma. Oral Oncol. 2002; Apr. 38(3):309–12.

213. Pitman KT, Johnson JT, Myers EN. Effectiveness of selective neck dissection for management of the clinically negative neck. Arch Otolaryngol Head Neck Surg. 1997; Sep. 123(9):917–22.

214. Byers RM. Modified neck dissection: a study of 967 cases from 1970 to 1980. Am J Surg. 1985; Oct. 150(4):414–21.

215. Li W, Xu Z, Liu F, Huang S, Dai W, Sun C. Vascularized free forearm flap versus free anterolateral thigh perforator flaps for reconstruction in patients with head and neck cancer: assessment of quality of life. Head Neck. 2013; Dec. 35(12):1808–13.

216. Guo CB, Feng Z, Zhang JG, Peng X, Cai ZG, Mao C, et al. Supraomohyoid neck dissection and modified radical neck dissection for clinically node-negative oral squamous cell carcinoma: a prospective study of prognosis, complications and quality of life. J Craniomaxillofac Surg. 2014; Dec. 42(8):1885–90.

217. Kou Y, Zhao T, Huang S, Liu J, Duan W, Wang Y, et al. Cervical level IIb metastases in squamous cell carcinoma of the oral cavity: a systematic review and meta-analysis. Onco Targets Ther. 2017; Sep. 10:4475–83.

218. Lea J, Bachar G, Sawka AM, Lakra DC, Gilbert RW, Irish JC, et al. Metastases to level IIb in squamous cell carcinoma of the oral cavity: a systematic review and meta-analysis. Head Neck. 2010; Feb. 32(2):184–90.

219. Pantvaidya GH, Pal P, Vaidya AD, Pai PS, D’Cruz AK. Prospective study of 583 neck dissections in oral cancers: implications for clinical practice. Head Neck. 2014; Oct. 36(10):1503–7.

220. Bhattacharya A, Adwani D, Adwani N, Sharma V. Is it worthy? Removal of level IIB nodes during selective neck dissection (I-III) for oral carcinomas. Ann Maxillofac Surg. 2015; Jan-Jun. 5(1):20–5.

221. DiNardo LJ. Lymphatics of the submandibular space: an anatomic, clinical, and pathologic study with applications to floor-of-mouth carcinoma. Laryngoscope. 1998; Feb. 108(2):206–14.

222. Lim YC, Kim JW, Koh YW, Kim K, Kim HJ, Kim KM, et al. Perivascular-submandibular lymph node metastasis in squamous cell carcinoma of the tongue and floor of mouth. Eur J Surg Oncol. 2004; Aug. 30(6):692–8.

223. Agarwal SK, Arora SK, Kumar G, Sarin D. Isolated perifacial lymph node metastasis in oral squamous cell carcinoma with clinically node-negative neck. Laryngoscope. 2016; Oct. 126(10):2252–6.

224. Paleri V, Rees G, Arullendran P, Shoaib T, Krishman S. Sentinel node biopsy in squamous cell cancer of the oral cavity and oral pharynx: a diagnostic meta-analysis. Head Neck. 2005; Sep. 27(9):739–47.

225. Civantos FJ, Zitsch RP, Schuller DE, Agrawal A, Smith RB, Nason R, et al. Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. J Clin Oncol. 2010; Mar. 28(8):1395–400.

226. Murer K, Huber GF, Haile SR, Stoeckli SJ. Comparison of morbidity between sentinel node biopsy and elective neck dissection for treatment of the n0 neck in patients with oral squamous cell carcinoma. Head Neck. 2011; Sep. 33(9):1260–4.

227. Schiefke F, Akdemir M, Weber A, Akdemir D, Singer S, Frerich B. Function, postoperative morbidity, and quality of life after cervical sentinel node biopsy and after selective neck dissection. Head Neck. 2009; Apr. 31(4):503–12.

228. Fielding LP, Fenoglio-Preiser CM, Freedman LS. The future of prognostic factors in outcome prediction for patients with cancer. Cancer. 1992; Nov. 70(9):2367–77.

229. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer. 1993; Jan. 71(2):452–6.

230. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1972; Jun. 29(6):1446–9.

231. Johnson JT, Myers EN, Bedetti CD, Barnes EL, Schramm VL Jr, Thearle PB. Cervical lymph node metastases: incidence and implications of extracapsular carcinoma. Arch Otolaryngol. 1985; Aug. 111(8):534–7.

232. Liao CT, Hsueh C, Lee LY, Lin CY, Fan KH, Wang HM, et al. Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy. Oral Oncol. 2012; Apr. 48(4):329–36.

233. Ong W, Zhao R, Lui B, Tan W, Ebrahimi A, Clark JR, et al. Prognostic significance of lymph node density in squamous cell carcinoma of the tongue. Head Neck. 2016; Apr. 38 Suppl 1:E859–66.

234. Ho CM, Lam KH, Wei WI, Lau WF. Treatment of neck nodes in oral cancer. Surg Oncol. 1992; Feb. 1(1):73–8.

235. Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer. 1990; Jul. 66(1):109–13.

236. Davidson BJ, Kulkarny V, Delacure MD, Shah JP. Posterior triangle metastases of squamous cell carcinoma of the upper aerodigestive tract. Am J Surg. 1993; Oct. 166(4):395–8.

237. Andersen PE, Warren F, Spiro J, Burningham A, Wong R, Wax MK, et al. Results of selective neck dissection in management of the node-positive neck. Arch Otolaryngol Head Neck Surg. 2002; Oct. 128(10):1180–4.

238. Byers RM, Wolf PF, Ballantyne AJ. Rationale for elective modified neck dissection. Head Neck Surg. 1988; Jan-Feb. 10(3):160–7.

239. Kerrebijn JD, Freeman JL, Irish JC, Witterick IJ, Brown DH, Rotstein LE, et al. Supraomohyoid neck dissection. Is it diagnostic or therapeutic. Head Neck. 1999; Jan. 21(1):39–42.

240. Kolli VR, Datta RV, Orner JB, Hicks WL Jr, Loree TR. The role of supraomohyoid neck dissection in patients with positive nodes. Arch Otolaryngol Head Neck Surg. 2000; Mar. 126(3):413–6.

241. Santos AB, Cernea CR, Inoue M, Ferraz AR. Selective neck dissection for node-positive necks in patients with head and neck squamous cell carcinoma: a word of caution. Arch Otolaryngol Head Neck Surg. 2006; Jan. 132(1):79–81.

242. Koo BS, Lim YC, Lee JS, Choi EC. Management of contralateral N0 neck in oral cavity squamous cell carcinoma. Head Neck. 2006; Oct. 28(10):896–901.

243. Habib M, Murgasen J, Gao K, Ashford B, Shannon K, Ebrahimi A, et al. Contralateral neck failure in lateralized oral squamous cell carcinoma. ANZ J Surg. 2016; Mar. 86(3):188–92.

244. Kurita H, Koike T, Narikawa JN, Sakai H, Nakatsuka A, Uehara S, et al. Clinical predictors for contralateral neck lymph node metastasis from unilateral squamous cell carcinoma in the oral cavity. Oral Oncol. 2004; Oct. 40(9):898–903.

245. Liao CT, Huang SF, Chen IH, Chang JT, Wang HM, Ng SH, et al. Risk stratification of patients with oral cavity squamous cell carcinoma and contralateral neck recurrence following radical surgery. Ann Surg Oncol. 2009; Jan. 16(1):159–70.

246. Ragbir M, Brown JS, Mehanna H. Reconstructive considerations in head and neck surgical oncology: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016; May. 130(S2):S191–7.

247. Kao SS, Peters MD, Krishnan SG, Ooi EH. Swallowing outcomes following primary surgical resection and primary free flap reconstruction for oral and oropharyngeal squamous cell carcinomas: a systematic review. Laryngoscope. 2016; Jul. 126(7):1572–80.

248. Lam L, Samman N. Speech and swallowing following tongue cancer surgery and free flap reconstruction: a systematic review. Oral Oncol. 2013; Jun. 49(6):507–24.

249. Hsiao HT, Leu YS, Lin CC. Primary closure versus radial forearm flap reconstruction after hemiglossectomy: functional assessment of swallowing and speech. Ann Plast Surg. 2002; Dec. 49(6):612–6.

250. Hsiao HT, Leu YS, Chang SH, Lee JT. Swallowing function in patients who underwent hemiglossectomy: comparison of primary closure and free radial forearm flap reconstruction with videofluoroscopy. Ann Plast Surg. 2003; May. 50(5):450–5.

251. Uwiera T, Seikaly H, Rieger J, Chau J, Harris JR. Functional outcomes after hemiglossectomy and reconstruction with a bilobed radial forearm free flap. J Otolaryngol. 2004; Dec. 33(6):356–9.

252. Riemann M, Knipfer C, Rohde M, Adler W, Schuster M, Noeth E, et al. Oral squamous cell carcinoma of the tongue: prospective and objective speech evaluation of patients undergoing surgical therapy. Head Neck. 2016; Jul. 38(7):993–1001.

253. Hanasono MM, Matros E, Disa JJ. Important aspects of head and neck reconstruction. Plast Reconstr Surg. 2014; Dec. 134(6):968e–980e.

254. Dziegielewski PT, Ho ML, Rieger J, Singh P, Langille M, Harris JR, et al. Total glossectomy with laryngeal preservation and free flap reconstruction: objective functional outcomes and systematic review of the literature. Laryngoscope. 2013; Jan. 123(1):140–5.

255. Manrique OJ, Leland HA, Langevin CJ, Wong A, Carey JN, Ciudad P, et al. Optimizing outcomes following total and subtotal tongue reconstruction: a systematic review of the contemporary literature. J Reconstr Microsurg. 2017; Feb. 33(2):103–11.

256. Yanai C, Kikutani T, Adachi M, Thoren H, Suzuki M, Iizuka T. Functional outcome after total and subtotal glossectomy with free flap reconstruction. Head Neck. 2008; Jul. 30(7):909–18.

257. Ayad T, Xie L. Facial artery musculomucosal flap in head and neck reconstruction: a systematic review. Head Neck. 2015; Sep. 37(9):1375–86.

258. Chien CY, Hwang CF, Chuang HC, Jeng SF, Su CY. Comparison of radial forearm free flap, pedicled buccal fat pad flap and split-thickness skin graft in reconstruction of buccal mucosal defect. Oral Oncol. 2005; Aug. 41(7):694–7.

259. Chuang HC, Su CY, Jeng SF, Chien CY. Anterior lateral thigh flap for buccal mucosal defect after resection of buccal cancer. Otolaryngol Head Neck Surg. 2007; Oct. 137(4):632–5.

260. Fang QG, Li ZN, Zhang X, Liu FY, Xu ZF, Sun CF. Clinical reliability of radial forearm free flap in repair of buccal defects. World J Surg Oncol. 2013; Jan. 11:26.

261. Savant DN, Patel SG, Deshmukh SP, Gujarati R, Bhathena HM, Kavarana NM. Folded free radial forearm flap for reconstruction of full-thickness defects of the cheek. Head Neck. 1995; Jul-Aug. 17(4):293–6.

262. Liu F, Wang L, Pang S, Kan Q. Reconstruction of full-thickness buccal defects with folded radial forearm flaps: a retrospective clinical study. Medicine (Baltimore). 2017; Aug. 96(32):e7344.

263. Brown JS, Barry C, Ho M, Shaw R. A new classification for mandibular defects after oncological resection. Lancet Oncol. 2016; Jan. 17(1):e23–30.

264. Wang KH, Inman JC, Hayden RE. Modern concepts in mandibular reconstruction in oral and oropharyngeal cancer. Curr Opin Otolaryngol Head Neck Surg. 2011; Apr. 19(2):119–24.

265. Moubayed SP, L’Heureux-Lebeau B, Christopoulos A, Sampalis JS, Letourneau-Guillon L, Bissada E, et al. Osteocutaneous free flaps for mandibular reconstruction: systematic review of their frequency of use and a preliminary quality of life comparison. J Laryngol Otol. 2014; Dec. 128(12):1034–43.

266. Zavalishina L, Karra N, Zaid WS, El-Hakim M. Quality of life assessment in patients after mandibular resection and free fibula flap reconstruction. J Oral Maxillofac Surg. 2014; Aug. 72(8):1616–26.

267. Okura M, Isomura ET, Iida S, Kogo M. Long-term outcome and factors influencing bridging plates for mandibular reconstruction. Oral Oncol. 2005; Sep. 41(8):791–8.

268. Miyamoto I, Yamashita Y, Yamamoto N, Nogami S, Yamauchi K, Yoshiga D, et al. Evaluation of mandibular reconstruction with particulate cancellous bone marrow and titanium mesh after mandibular resection due to tumor surgery. Implant Dent. 2014; Apr. 23(2):108–15.

269. van Gemert J, Holtslag I, van der Bilt A, Merkx M, Koole R, Van Cann E. Health-related quality of life after segmental resection of the lateral mandible: free fibula flap versus plate reconstruction. J Craniomaxillofac Surg. 2015; Jun. 43(5):658–62.

270. Seitz O, Harth M, Ghanaati S, Lehnert T, Vogl TJ, Sader R, et al. Secondary mandibular reconstruction after oral squamous cell carcinoma resection: clinical reevaluation of transport disk distraction osteogenesis. J Craniofac Surg. 2010; Jan. 21(1):59–63.

271. Wang JJ, Chen J, Ping FY, Yan Fg. Double-step transport distraction osteogenesis in the reconstruction of unilateral large mandibular defects after tumour resection using internal distraction devices. Int J Oral Maxillofac Surg. 2012; May. 41(5):587–95.

272. Kontio R. Update on mandibular reconstruction: computer-aided design, imaging, stem cells and future applications. Curr Opin Otolaryngol Head Neck Surg. 2014; Aug. 22(4):307–15.

273. Hayden RE, Mullin DP, Patel AK. Reconstruction of the segmental mandibular defect: current state of the art. Curr Opin Otolaryngol Head Neck Surg. 2012; Aug. 20(4):231–6.

274. Han HH, Kim HY, Lee JY. The pros and cons of computer-aided surgery for segmental mandibular reconstruction after oncological surgery. Arch Craniofac Surg. 2017; Sep. 18(3):149–54.

275. Yoshimura H, Matsuda S, Ohba S, Minegishi Y, Nakai K, Fujieda S, et al. Stereolithographic model-assisted reconstruction of the mandibular condyle with a vascularized fibular flap following hemimandibulectomy: evaluation of morphological and functional outcomes. Oncol Lett. 2017; Nov. 14(5):5471–83.

276. Ciocca L, Mazzoni S, Fantini M, Persiani F, Baldissara P, Marchetti C, et al. A CAD/CAM-prototyped anatomical condylar prosthesis connected to a custom-made bone plate to support a fibula free flap. Med Biol Eng Comput. 2012; Jul. 50(7):743–9.

277. Antony AK, Chen WF, Kolokythas A, Weimer KA, Cohen MN. Use of virtual surgery and stereolithography-guided osteotomy for mandibular reconstruction with the free fibula. Plast Reconstr Surg. 2011; Nov. 128(5):1080–4.

278. Joshi A, Calman F, O’Connell M, Jeannon JP, Pracy P, Simo R. Current trends in the follow-up of head and neck cancer patients in the UK. Clin Oncol (R Coll Radiol). 2010; Mar. 22(2):114–8.

279. Digonnet A, Hamoir M, Andry G, Haigentz M Jr, Takes RP, Silver CE, et al. Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2013; May. 270(5):1569–80.

280. Haas I, Hauser U, Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol. 2001; May. 258(4):177–83.

281. Collins R, Flynn A, Melville A, Richardson R, Eastwood A. Effective health care: management of head and neck cancers. Qual Saf Health Care. 2005; Apr. 14(2):144–8.

282. Morton RP, Hay KD, Macann A. On completion of curative treatment of head and neck cancer: why follow up. Curr Opin Otolaryngol Head Neck Surg. 2004; Apr. 12(2):142–6.

283. Boysen M, Lovdal O, Tausjo J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer. 1992; 28(2-3):426–30.

284. Boysen M. Value of follow-up in patients treated for squamous cell carcinomas of the oral cavity and oropharynx. Recent Results Cancer Res. 1994; 134:205–14.

285. Virgo KS, Paniello RC, Johnson FE. Costs of posttreatment surveillance for patients with upper aerodigestive tract cancer. Arch Otolaryngol Head Neck Surg. 1998; May. 124(5):564–72.

286. van Agthoven M, van Ineveld BM, de Boer MF, Leemans CR, Knegt PP, Snow GB, et al. The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up. Eur J Cancer. 2001; Nov. 37(17):2204–11.

287. British Association of Head, Neck Oncologists. Practice care guidance for clinicians participating in the management of head and neck cancer patients in the UK. Drawn up by a Consensus Group of Practising Clinicians. Eur J Surg Oncol. 2001; Jun. 27 Suppl A:S1–17.

288. Marchant FE, Lowry LD, Moffitt JJ, Sabbagh R. Current national trends in the posttreatment follow-up of patients with squamous cell carcinoma of the head and neck. Am J Otolaryngol. 1993; Mar-Apr. 14(2):88–93.

289. Kothari P, Trinidade A, Hewitt RJ, Singh A, O’Flynn P. The follow-up of patients with head and neck cancer: an analysis of 1,039 patients. Eur Arch Otorhinolaryngol. 2011; Aug. 268(8):1191–200.

290. Trinidade A, Kothari P, Andreou Z, Hewitt RJ, O’Flynn P. Follow-up in head and neck cancer: patients’ perspective. Int J Health Care Qual Assur. 2012; 25(2):145–9.

291. Schwartz DL, Barker J Jr, Chansky K, Yueh B, Raminfar L, Drago P, et al. Postradiotherapy surveillance practice for head and neck squamous cell carcinoma: too much for too little. Head Neck. 2003; Dec. 25(12):990–9.

292. Ul-Hassan F, Simo R, Guerrero-Urbano T, Oakley R, Jeannon JP, Cook GJ. Can (18)F-FDG PET/CT reliably assess response to primary treatment of head and neck cancer. Clin Nucl Med. 2013; Apr. 38(4):263–5.

293. Isles MG, McConkey C, Mehanna HM. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol. 2008; Jun. 33(3):210–22.

294. de Visscher AV, Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense. Arch Otolaryngol Head Neck Surg. 1994; Sep. 120(9):934–9.

295. Warner GC, Cox GJ. Evaluation of chest radiography versus chest computed tomography in screening for pulmonary malignancy in advanced head and neck cancer. J Otolaryngol. 2003; Apr. 32(2):107–9.

296. Steinkamp HJ, Maurer J, Cornehl M, Knobber D, Hettwer H, Felix R. Recurrent cervical lymphadenopathy: differential diagnosis with color-duplex sonography. Eur Arch Otorhinolaryngol. 1994; 251(7):404–9.

297. Westhofen M. Ultrasound B-scans in the follow-up of head and neck tumors. Head Neck Surg. 1987; May-Jun. 9(5):272–8.

298. Ahuja A, Leung SF, Ying M, Metreweli C. Echography of metastatic nodes treated by radiotherapy. J Laryngol Otol. 1999; Nov. 113(11):993–8.

299. O’Meara WP, Thiringer JK, Johnstone PA. Follow-up of head and neck cancer patients post-radiotherapy. Radiother Oncol. 2003; Mar. 66(3):323–6.

300. Lapela M, Eigtved A, Jyrkkio S, Grenman R, Kurki T, Lindholm P, et al. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer. 2000; May. 36(7):858–67.

301. Manikantan K, Khode S, Dwivedi RC, Palav R, Nutting CM, Rhys-Evans P, et al. Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up. Cancer Treat Rev. 2009; Dec. 35(8):744–53.

302. Gold KA, Kim ES. Role of molecular markers and gene profiling in head and neck cancers. Curr Opin Oncol. 2009; May. 21(3):206–11.

303. Braakhuis BJ, Brakenhoff RH, Leemans CR. Gene expression profiling in head and neck squamous cell carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2010; Apr. 18(2):67–71.

304. Sinard RJ, Tobin EJ, Mazzaferri EL, Hodgson SE, Young DC, Kunz AL, et al. Hypothyroidism after treatment for nonthyroid head and neck cancer. Arch Otolaryngol Head Neck Surg. 2000; May. 126(5):652–7.

305. Colevas AD, Read R, Thornhill J, Adak S, Tishler R, Busse P, et al. Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2001; Nov. 51(3):599–604.

306. Posner MR, Ervin TJ, Miller D, Fabian RL, Norris CM Jr, Weichselbaum RR, et al. Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck. Laryngoscope. 1984; Apr. 94(4):451–54.

307. Tell R, Lundell G, Nilsson B, Sjodin H, Lewin F, Lewensohn R. Long- term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004; Oct. 60(2):395–400.

308. Francis DO, Weymuller EA Jr, Parvathaneni U, Merati AL, Yueh B. Dysphagia, stricture, and pneumonia in head and neck cancer patients: does treatment modality matter. Ann Otol Rhinol Laryngol. 2010; Jun. 119(6):391–7.

309. Murphy BA, Gilbert J. Dysphagia in head and neck cancer patients treated with radiation: assessment, sequelae, and rehabilitation. Semin Radiat Oncol. 2009; Jan. 19(1):35–42.

310. Crary MA, Carnaby GD, LaGorio LA, Carvajal PJ. Functional and physiological outcomes from an exercise-based dysphagia therapy: a pilot investigation of the McNeill Dysphagia Therapy Program. Arch Phys Med Rehabil. 2012; Jul. 93(7):1173–8.

311. Lan Y, Ohkubo M, Berretin-Felix G, Sia I, Carnaby-Mann GD, Crary MA. Normalization of temporal aspects of swallowing physiology after the McNeill dysphagia therapy program. Ann Otol Rhinol Laryngol. 2012; Aug. 121(8):525–32.

312. Crary MA, Carnaby Mann GD, Groher ME, Helseth E. Functional benefits of dysphagia therapy using adjunctive sEMG biofeedback. Dysphagia. 2004; Summer. 19(3):160–4.

313. Shaker R, Easterling C, Kern M, Nitschke T, Massey B, Daniels S, et al. Rehabilitation of swallowing by exercise in tube-fed patients with pharyngeal dysphagia secondary to abnormal UES opening. Gastroenterology. 2002; May. 122(5):1314–21.

314. Logemann JA, Pauloski BR, Rademaker AW, Lazarus CL, Gaziano J, Stachowiak L, et al. Swallowing disorders in the first year after radiation and chemoradiation. Head Neck. 2008; Feb. 30(2):148–58.

315. Tuomi L, Andrell P, Finizia C. Effects of voice rehabilitation after radiation therapy for laryngeal cancer: a randomized controlled study. Int J Radiat Oncol Biol Phys. 2014; Aug. 89(5):964–72.

316. van Gogh CD, Verdonck-de Leeuw IM, Langendijk JA, Kuik DJ, Mahieu HF. Long-term efficacy of voice therapy in patients with voice problems after treatment of early glottic cancer. J Voice. 2012; May. 26(3):398–401.

317. Xi S. Effectiveness of voice rehabilitation on vocalisation in postlaryngectomy patients: a systematic review. Int J Evid Based Healthc. 2010; Dec. 8(4):256–8.

318. Marunick M, Tselios N. The efficacy of palatal augmentation prostheses for speech and swallowing in patients undergoing glossectomy: a review of the literature. J Prosthet Dent. 2004; Jan. 91(1):67–74.

319. McNeely ML, Parliament M, Courneya KS, Seikaly H, Jha N, Scrimger R, et al. A pilot study of a randomized controlled trial to evaluate the effects of progressive resistance exercise training on shoulder dysfunction caused by spinal accessory neurapraxia/neurectomy in head and neck cancer survivors. Head Neck. 2004; Jun. 26(6):518–30.

320. McNeely ML, Parliament MB, Seikaly H, Jha N, Magee DJ, Hay-kowsky MJ, et al. Effect of exercise on upper extremity pain and dysfunction in head and neck cancer survivors: a randomized controlled trial. Cancer. 2008; Jul. 113(1):214–22.

321. Carvalho AP, Vital FM, Soares BG. Exercise interventions for shoulder dysfunction in patients treated for head and neck cancer. Cochrane Database Syst Rev. 2012; Apr. (4):CD008693.

322. Lauchlan DT, McCaul JA, McCarron T, Patil S, McManners J, McGarva J. An exploratory trial of preventative rehabilitation on shoulder disability and quality of life in patients following neck dissection surgery. Eur J Cancer Care (Engl). 2011; Jan. 20(1):113–22.

323. Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012; Jul-Aug. 62(4):243–74.

324. Hashibe M, Hunt J, Wei M, Buys S, Gren L, Lee YC. Tobacco, alcohol, body mass index, physical activity, and the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort. Head Neck. 2013; Jul. 35(7):914–22.

325. Dijkstra PU, van Wilgen PC, Buijs RP, Brendeke W, de Goede CJ, Kerst A, et al. Incidence of shoulder pain after neck dissection: a clinical explorative study for risk factors. Head Neck. 2001; Nov. 23(11):947–53.

326. Samuel SR, Maiya GA, Babu AS, Vidyasagar MS. Effect of exercise training on functional capacity & quality of life in head & neck cancer patients receiving chemoradiotherapy. Indian J Med Res. 2013; Mar. 137(3):515–20.

327. Nekhlyudov L, Lacchetti C, Davis NB, Garvey TQ, Goldstein DP, Nunnink JC, et al. Head and neck cancer survivorship care guideline: American Society of Clinical Oncology clinical practice guideline endorsement of the American Cancer Society guideline. J Clin Oncol. 2017; May. 35(14):1606–21.

328. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988; Jun. 48(11):3282–7.

329. Freedman ND, Schatzkin A, Leitzmann MF, Hollenbeck AR, Abnet CC. Alcohol and head and neck cancer risk in a prospective study. Br J Cancer. 2007; May. 96(9):1469–74.

330. Alcohol drinking. IARC Working Group, Lyon, 13-20 October 1987. IARC Monogr Eval Carcinog Risks Hum. 1988; 44:1–378.

331. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Alcohol consumption and ethyl carbamate. IARC Monogr Eval Carcinog Risks Hum. 2010; 96:3–1383.

332. Morris LG, Sikora AG, Hayes RB, Patel SG, Ganly I. Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer. Cancer Causes Control. 2011; May. 22(5):671–9.

333. Howren MB, Christensen AJ, Karnell LH, Funk GF. Psychological factors associated with head and neck cancer treatment and survivorship: evidence and opportunities for behavioral medicine. J Consult Clin Psychol. 2013; Apr. 81(2):299–317.

334. Nayan S, Gupta MK, Strychowsky JE, Sommer DD. Smoking cessation interventions and cessation rates in the oncology population: an updated systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2013; Aug. 149(2):200–11.

335. Siegel RL, Jacobs EJ, Newton CC, Feskanich D, Freedman ND, Prentice RL, et al. Deaths due to cigarette smoking for 12 smoking-related cancers in the United States. JAMA Intern Med. 2015; Sep. 175(9):1574–6.

336. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012; 100(Pt E):1–538.

337. Ostroff JS, Jacobsen PB, Moadel AB, Spiro RH, Shah JP, Strong EW, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995; Jan. 75(2):569–76.

338. Gritz ER, Nisenbaum R, Elashoff RE, Holmes EC. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control. 1991; Mar. 2(2):105–12.

339. Dresler CM, Bailey M, Roper CR, Patterson GA, Cooper JD. Smoking cessation and lung cancer resection. Chest. 1996; Nov. 110(5):1199–202.

340. Walker MS, Larsen RJ, Zona DM, Govindan R, Fisher EB. Smoking urges and relapse among lung cancer patients: findings from a preliminary retrospective study. Prev Med. 2004; Sep. 39(3):449–57.

341. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010; Jan. 340:b5569.

342. Kawahara M, Ushijima S, Kamimori T, Kodama N, Ogawara M, Matsui K, et al. Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation. Br J Cancer. 1998; Aug. 78(3):409–12.

343. Do KA, Johnson MM, Doherty DA, Lee JJ, Wu XF, Dong Q, et al. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control. 2003; Mar. 14(2):131–8.

344. Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993; Jan. 328(3):159–63.

345. Zhang J, Kamdar O, Le W, Rosen GD, Upadhyay D. Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer. Am J Respir Cell Mol Biol. 2009; Feb. 40(2):135–46.

346. Zevallos JP, Mallen MJ, Lam CY, Karam-Hage M, Blalock J, Wetter DW, et al. Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. Cancer. 2009; Oct. 115(19):4636–44.

347. Moller AM, Pedersen T, Villebro N, Schnaberich A, Haas M, Tonnesen R. A study of the impact of long-term tobacco smoking on postoperative intensive care admission. Anaesthesia. 2003; Jan. 58(1):55–9.

348. Jerjes W, Upile T, Radhi H, Petrie A, Abiola J, Adams A, et al. The effect of tobacco and alcohol and their reduction/cessation on mortality in oral cancer patients: short communication. Head Neck Oncol. 2012; Mar. 4:6.

349. Epstein JB, Guneri P, Barasch A. Appropriate and necessary oral care for people with cancer: guidance to obtain the right oral and dental care at the right time. Support Care Cancer. 2014; Jul. 22(7):1981–8.

350. Epstein JB, Thariat J, Bensadoun RJ, Barasch A, Murphy BA, Kolnick L, et al. Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin. 2012; Nov-Dec. 62(6):400–22.

351. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014; Jul-Aug. 64(4):252–71.

352. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; Jan-Feb. 65(1):5–29.

353. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013; Sep. 7(3):300–22.

354. Boyes AW, Girgis A, Zucca AC, Lecathelinais C. Anxiety and depression among long-term survivors of cancer in Australia: results of a population-based survey. Comment. Med J Aust. 2009; Sep. 191(5):295.

355. Hoffman KE, McCarthy EP, Recklitis CJ, Ng AK. Psychological distress in long-term survivors of adult-onset cancer: results from a national survey. Arch Intern Med. 2009; Jul. 169(14):1274–81.

356. Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol. 2013; Jul. 14(8):721–32.

357. Buchmann L, Conlee J, Hunt J, Agarwal J, White S. Psychosocial distress is prevalent in head and neck cancer patients. Laryngoscope. 2013; Jun. 123(6):1424–9.

358. Funk GF, Karnell LH, Christensen AJ. Long-term health-related quality of life in survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2012; Feb. 138(2):123–33.

359. Posluszny DM, Dougall AL, Johnson JT, Argiris A, Ferris RL, Baum A, et al. Posttraumatic stress disorder symptoms in newly diagnosed patients with head and neck cancer and their partners. Head Neck. 2015; Sep. 37(9):1282–9.

360. Lydiatt WM, Moran J, Burke WJ. A review of depression in the head and neck cancer patient. Clin Adv Hematol Oncol. 2009; Jun. 7(6):397–403.

361. Devins GM, Payne AY, Lebel S, Mah K, Lee RN, Irish J, et al. The burden of stress in head and neck cancer. Psychooncology. 2013; Mar. 22(3):668–76.

362. Andersen BL, Rowland JH, Somerfield MR. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology Guideline adaptation. J Oncol Pract. 2015; Mar. 11(2):133–4.

363. Gonzalez-Garcia R. The role of salvage surgery in oral squamous cell carcinoma. Plast Aesthet Res. 2016; 3:189–96.

364. Schwartz GJ, Mehta RH, Wenig BL, Shaligram C, Portugal LG. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity. Head Neck. 2000; Jan. 22(1):34–41.

365. Kowalski LP. Results of salvage treatment of the neck in patients with oral cancer. Arch Otolaryngol Head Neck Surg. 2002; Jan. 128(1):58–62.

366. Lin YC, Hsiao JR, Tsai ST. Salvage surgery as the primary treatment for recurrent oral squamous cell carcinoma. Oral Oncol. 2004; Feb. 40(2):183–9.

367. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, et al. Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: how and when. Cancer. 2008; Jan. 112(1):94–103.

368. Agra IM, Carvalho AL, Ulbrich FS, de Campos OD, Martins EP, Magrin J, et al. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck. 2006; Feb. 28(2):107–13.

369. Brown JS, Blackburn TK, Woolgar JA, Lowe D, Errington RD, Vaughan ED, et al. A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with post-operative radiotherapy. Oral Oncol. 2007; Sep. 43(8):764–73.

370. Koo BS, Lim YC, Lee JS, Choi EC. Recurrence and salvage treatment of squamous cell carcinoma of the oral cavity. Oral Oncol. 2006; Sep. 42(8):789–94.

371. Bataini JP. Radiotherapy in N0 head and neck cancer patients. Eur Arch Otorhinolaryngol. 1993; 250(8):442–5.

372. Wei WI, Ferlito A, Rinaldo A, Gourin CG, Lowry J, Ho WK, et al. Management of the N0 neck: reference or preference. Oral Oncol. 2006; Feb. 42(2):115–22.

373. Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg. 1994; Jul. 120(7):699–702.

374. Fakih AR, Rao RS, Patel AR. Prophylactic neck dissection in squamous cell carcinoma of oral tongue: a prospective randomized study. Semin Surg Oncol. 1989; 5(5):327–30.

375. Ferlito A, Shaha AR, Rinaldo A. The incidence of lymph node micrometastases in patients pathologically staged N0 in cancer of oral cavity and oropharynx. Oral Oncol. 2002; Jan. 38(1):3–5.

376. Jones AS, Tandon S, Helliwell TR, Husband DJ, Jones TM. Survival of patients with neck recurrence following radical neck dissection: utility of a second neck dissection. Head Neck. 2008; Nov. 30(11):1514–22.

377. Yao M, Roebuck JC, Holsinger FC, Myers JN. Elective neck dissection during salvage laryngectomy. Am J Otolaryngol. 2005; Nov-Dec. 26(6):388–92.

378. Yuen AP, Wei WI, Ho CM. Results of surgical salvage for radiation failures of laryngeal carcinoma. Otolaryngol Head Neck Surg. 1995; Mar. 112(3):405–9.

379. Dagan R, Morris CG, Kirwan JM, Werning JW, Vaysberg M, Amdur RJ, et al. Elective neck dissection during salvage surgery for locally recurrent head and neck squamous cell carcinoma after radiotherapy with elective nodal irradiation. Laryngoscope. 2010; May. 120(5):945–52.

380. Yirmibesoglu E, Fried D, Shores C, Rosenman J, Weissler M, Hackman T, et al. Incidence of subclinical nodal disease at the time of salvage surgery for locally recurrent head and neck cancer initially treated with definitive radiation therapy. Am J Clin Oncol. 2013; Oct. 36(5):475–80.

381. Solares CA, Fritz MA, Esclamado RM. Oncologic effectiveness of selective neck dissection in the N0 irradiated neck. Head Neck. 2005; May. 27(5):415–20.

382. Lee DJ, Kwon KH, Chung EJ, Park IS, Kim JH, Rho YS. The role of elective neck dissection during salvage surgery in head and neck squamous cell carcinoma. Acta Otolaryngol. 2013; Aug. 133(8):886–92.

383. Wong LY, Wei WI, Lam LK, Yuen AP. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck. 2003; Nov. 25(11):953–9.

384. Sun LM, Leung SW, Su CY, Wang CJ. The relapse patterns and outcome of postoperative recurrent tongue cancer. J Oral Maxillofac Surg. 1997; Aug. 55(8):827–31.

385. Gleich LL, Ryzenman J, Gluckman JL, Wilson KM, Barrett WL, Redmond KP. Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible. Arch Otolaryngol Head Neck Surg. 2004; Jan. 130(1):35–8.

386. Ord RA, Kolokythas A, Reynolds MA. Surgical salvage for local and regional recurrence in oral cancer. J Oral Maxillofac Surg. 2006; Sep. 64(9):1409–14.